Based on assessment of an extended osteosarcoma-focused cell line panel, we here report selective sensitivity of RB1-defective osteosarcoma to inhibitors of poly-(ADP-ribose)-polymerase1,2 (PARPi). Here, RB1 is linked to osteosarcoma.